These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Telomerase and its potential for therapeutic intervention. Phatak P; Burger AM Br J Pharmacol; 2007 Dec; 152(7):1003-11. PubMed ID: 17603541 [TBL] [Abstract][Full Text] [Related]
4. Functional and mechanistic analysis of telomerase: An antitumor drug target. Chen Y; Zhang Y Pharmacol Ther; 2016 Jul; 163():24-47. PubMed ID: 27118336 [TBL] [Abstract][Full Text] [Related]
5. Telomeres and telomerase: Pharmacological targets for new anticancer strategies? Pendino F; Tarkanyi I; Dudognon C; Hillion J; Lanotte M; Aradi J; Ségal-Bendirdjian E Curr Cancer Drug Targets; 2006 Mar; 6(2):147-80. PubMed ID: 16529544 [TBL] [Abstract][Full Text] [Related]
6. How to inhibit telomerase activity for cancer therapy. Kyo S; Inoue M Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728 [TBL] [Abstract][Full Text] [Related]
7. Anticancer therapy targeting telomeres and telomerase : current status. Parkinson EK; Minty F BioDrugs; 2007; 21(6):375-85. PubMed ID: 18020621 [TBL] [Abstract][Full Text] [Related]
8. Agents that target telomerase and telomeres. Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642 [TBL] [Abstract][Full Text] [Related]
9. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs]. Raymond E; Faivre S; Dieras V; Von Hoff D Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365 [TBL] [Abstract][Full Text] [Related]
10. Telomerase inhibitors as anticancer therapy. Akiyama M; Hideshima T; Munshi NC; Anderson KC Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):567-75. PubMed ID: 12678724 [TBL] [Abstract][Full Text] [Related]
11. Telomere maintenance as a target for anticancer drug discovery. Neidle S; Parkinson G Nat Rev Drug Discov; 2002 May; 1(5):383-93. PubMed ID: 12120414 [TBL] [Abstract][Full Text] [Related]
12. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Jafri MA; Ansari SA; Alqahtani MH; Shay JW Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951 [TBL] [Abstract][Full Text] [Related]
13. Targeting telomerase for its advent in cancer therapeutics. Bajaj S; Kumar MS; Peters GJ; Mayur YC Med Res Rev; 2020 Sep; 40(5):1871-1919. PubMed ID: 32391613 [TBL] [Abstract][Full Text] [Related]
14. Telomere biology of pediatric cancer. Tabori U; Dome JS Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease. Tárkányi I; Aradi J Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408 [TBL] [Abstract][Full Text] [Related]
16. Telomere inhibition and telomere disruption as processes for drug targeting. Rezler EM; Bearss DJ; Hurley LH Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745 [TBL] [Abstract][Full Text] [Related]
17. Targeting human telomerase in cancer therapy. Huard S; Autexier C Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725 [TBL] [Abstract][Full Text] [Related]
18. Potential Telomere-Related Pharmacological Targets. Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516 [TBL] [Abstract][Full Text] [Related]
19. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors. Saraswati AP; Relitti N; Brindisi M; Gemma S; Zisterer D; Butini S; Campiani G Drug Discov Today; 2019 Jul; 24(7):1370-1388. PubMed ID: 31136800 [TBL] [Abstract][Full Text] [Related]
20. [Telomere and telomerase as targets for anti-cancer drugs]. Ide T Nihon Rinsho; 2004 Jul; 62(7):1271-6. PubMed ID: 15283143 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]